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Summary: Six immunological parameters, of which the most important are the quantitative distribution of the free
light chains, and the kappa-lambda ratios of both bound and free light chains, were investigated in serum of patients
affected with various neurological disorders and compared to controls.
Subacute sclerosing panencephalitis and viral encephalitis, which are diseases characterized by hyperimmunisation
against definite antigens, are accompanied by a considerable quantitative increase of free light chains; in subacute
sclerosing panencephalitis serum there is an increase of both free kappa and lambda chains, whereas in viral
encephalitis serum the increase of free light chains was restricted to lambda chains.
There is a good correlation between the kappa-lambda ratio of, on the one hand, bound light chains and, on the
other hand, free light chains for controls and subacute sclerosing panencephalitis; but in multiple sclerosis, amyo-
trophic lateral sclerosis and viral encephalitis, the ratios for bound light chains are totally different from ratios for
free ligjit chains. A general kappa increase, which we earlier reported for bound light chains in 16 cases of multiple
sclerosis, was not confirmed by the investigation of an additional 26 cases: kappa decrease was also noticed in a
considerable number of cases.
Gebundene und freie leichte Ketten im Serum von Patienten mit verschiedenen neurologischen Erkrankungen
Zusammenfassung: Sechs immunologische Größen — die wichtigsten sind die quantitative Verteilung der freien
leichten Ketten und die Kappa-Lambda-Verhältnisse sowohl der freien als auch der gebundenen leichten Ketten —
wurden im Serum von Patienten mit verschiedenen neurologischen Störungen untersucht und mit denen von Kon-
trollpersonen verglichen.
Subakute sklerosierende Panencephalitis und virale Encephalitis — Erkrankungen, die durch Hyperimmunisierung
gegen bestimmte Antigene charakterisiert sind — sind begleitet von einem beträchtlichen quantitativen Anstieg
freier leichter Ketten: im Serum von an subakuter sklerosierender Panencephalitis Erkrankten findet sich ein Anstieg
freier Kappa- und Lambda-Ketten, während der Anstieg der freien leichten Ketten im Serum an viraler Encephalitis
Erkrankter auf die Lambda-Ketten beschränkt war.
Es besteht eine gute Korrelation zwischen dem Kappa-Lambda-Verhältnis sowohl der gebundenen leichten Ketten
als auch der freien leichten Ketten bei den Kontrollpersonen und den an subakuter sklerosierender Panencephalitis
Erkrankten; bei multipler Sklerose, amyotropher Lateralsklerose und viraler Encephalitis jedoch differieren die
Verhältnisse für gebundene leichte Ketten völlig von denen für freie leichte Ketten. Ein genereller Anstieg der
Kappa-Ketten, den wir früher fiir gebundene leichte Ketten in 16 Fällen von multipler Sklerose beschrieben haben,
konnte bei Untersuchung zusätzlicher 26 Fälle nicht bestätigt werden: auch ein Abfall der Kappa-Ketten wurde in
einer beträchtlichen Zahl der Fälle festgestellt.
Introduction and serum from patients affected with various neuro-
In previous papers (1, 2, 3) we investigated qligoclpnal loßical ^seew-
immunoglobulins, light chain ratios, free light chains, For the cerebrospinal fluid there seemed to be a
the presence of the double ring formation in single correlation between the frequency of the presence of
radial immunodiffusion, agar gel electrophoresis and free light chains and the degree of severity of the immuno-
thin layer isofocüsing pattern in cerebrospinal fluid logical processes, or of hyperimmunisation, since this
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frequency was highest in subacute sclerosing panen-
cephalitis, neurosyphilis and viral encephalitis. We were
not then able to evaluate the free light chains in serum
from patients with the same neurological disorders, for
the lack of sufficient assays in amyotrophic lateral
sclerosis cases and controls.
In the present paper we should now like to report the
quantitative distribution of free light chains, and the
kappa-lambda ratio of bound and of free light chains in
the serum of patients grouped according to 4 different
neurological diseases, together with earlier results of
IgG content and agar gel electrophoresis pattern (3).
Elsewhere (3) we examined 16 sera of multiple sclerosis
patients and found a kappa increase for the kappa-lambda
ratios of bound light chains. We stated that this particular
feature, if thoroughly investigated on a larger number of
sera, could become important for the diagnosis of
multiple sclerosis. Consequently, in this paper we
considered 42 cases of multiple sclerosis in order to
evaluate the validity of the statement.
Material and Methods
We considered the following neurological diseases:
1. amyotrophic lateral sclerosis
2. multiple sclerosis
3. subacute sclerosing panencephalitis
4. viral encephalitis.
Diagnosis was based on the clinical course of the diseases, on the
electro-encephalogram, thorough routine examination of the
serum and cerebrospinal fluid (total proteins, cell counting,
etc.), agar gel electrophoresis, and when necessary, on titration
of the viral antibodies.
Pathological sera were used immediately or kept frozen at
- 35 °C. Control serum was taken from healthy donors and
assayed immediately. Agar gel electrophoresis was carried out
according to Wieme (4). The IgG content was measured by
single radial immunodiffusion, using Tripartigen plates1).
The bound and free light chain determinations were performed
by single radial immunodiffusion in agar plates with incorporated
bound and free light chain antiserum as described previously
(1). The standard curve was established with several dilutions
of reference kappa and lambda Bence-Jones proteins (1).
The statistical method used to investigate the different popula-
tions was the following: since a normal distribution cannot be
assumed in pathological states, we employed non parametrics
statistics, i. e. the U-test of Wilcoxon2).
Results
In order to avoid a multitude of tables, all the results
were grouped in a unique table in the form of mean
values; the significant differences between controls and
pathological values were calculated by the non para- '
metric Wilcoxon test (tab. 1). Nevertheless a global
description of individual values will be given.
For the control cases, IgG content and tfb/Xb3) were
as reported elsewhere (1,3). Free kappa chains and
lambda chains were present in all cases. The kappa-
lambda ratios of free light chains were very close to
those of bound chains.
The same parameters are reported for 11 cases of amyo-
trophic lateral sclerosis. Three cases had slightly elevated
IgG, one showed decreased IgG, but all fcb/Xb were lower
than those of the controls.
Free κ-chains were increased when compared to control
values, but free λ-chains had almost the same distribution
as controls, notwithstanding a few exceptions* No oligo-
clonal immunoglobulins were recorded.
We examined 42 cases of multiple sclerosis and this
represents a much larger group than we reported in an
earlier paper (3). They were grouped according to their
Kb/Xb4).
In group I of the 13 cases, 9 had normal IgG levels,
3 showed decreased levels and one had slightly elevated
IgG. All the fcb/Xb were, as mentioned above, higher than
or equal to control values.
Free κ-chains were decreased compared to the controls,
whereas free λ-chains showed almost no change. 5 of 11
Kf/Xf were frankly λ-predominant, while patient 8
presented a pure κ-chain population.
In agar gel electrophoresis one serum showed definite
oligoclonal immunoglobulins and three other samples
showed a tendency towards fractionation.
In group II, 3 out of 29 cases showed decreased IgG and
9 showed increased levels. /cb/Xb were widely spread
and 13 of them frankly X-predominant. Free κ-chains
were increased in almost every case when compared to
controls, but the free λ-chains were within the range
of control values. In agar gel electrophoresis three sera
showed oligoclonal immunoglobulins and one showed
a tendency towards fractionation.
The mean values of the multiple sclerosis parameters
grouped in table 1 clearly illustrate these findings.
As far as the 18 subacute sclerosing panencephalitis
patients are concerned, the well known IgG increase is
once more confirmed (1, 3). /cb/Xb were considerably
spread, ranging from 1.2 to 5.4. Free κ- as well as
λ-chains were increased when compared to control
values. Five sera were X-predominant, three displayed
only free X-chairis, one only free κ-chains and two
showed a considerable /c-increase.
In agar gel electrophoresis 17 out of 18 cases showed
fractionation. As demonstrated elsewhere (3) the IgG
values of 11 sera from patients affected with viral
encephalitis were considerably spread and /cb/Xb
*) Tripartigen - IgG TDS/03 - Behringwerke A. G. - Marburg/
Lahn.
2) Documenta Geigy - Tables scientifiques - Basel.
3) /cb/Xb = kappa-lambda ratio of bound .light chains.
4) Group I: /cb/Xb multiple sclerosis > /cb/Xb controls
Group II: /cb/Xb multiple sclerosis < fcb/Xb controls.
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* pathological values differ from controls for 2« = 0.01 (Wttcoxon test)
pathological values differ from controls for 2α = 0.02
* group I: *b/\b > «b/M> controls
** group II; fcb/Xb < *b/\b controls
values were slightly decreased in comparison to mean
control ones,
Free λ-chains were greatly increased when compared
to control values, whereas free ^chains were only
slightly increased. Consequently Kf/Xf were particularly
λ-predominant
Table 1 gives the mean values, the significant differences
between control and pathological sera and the frequency
of appearance Qf fractionated immunoglobulins in agar
gel electrophoresis. For the IgG values, all the earlier
results we reported in serum (3) are confirmed: only
subacute sclerosing panencephalitis differs significantly
from controls,
With respect to the Kb/Xb, earlier findings (3) are also
confirmed, although we divided the iftuch larger group
of multiple sclerosis into groups I and II; for both groups
the Kb/Xb differed significantly from controls.
When considering the free κ-chains, only multiple
sclerosis-group II differed from controls; with respect
to the free λ-chains, significant differences from controls
were found in subacute sclerosing panencephalitis and
viral encephalitis.
Multiple sclerosis and viral encephalitis display Kf/Xf,
which are significantly different from those of controls.
Finally,.the appearance of fractionated imm noglobulins
showed a high incidence in subacute sclerosing panen-
cephalitis sera, increasing from 14 to 18 cases. Screening
of a large multiple sclerosis group revealed the presence
of fractionated IgG in group I as well as in group II.
Discussion
In the group of neurological diseases we investigated^
only subacute sclerosing panencephalitis sera displayed
IgG values which were significantly different from
controls.
However, when grouping multiple sclerosis sera as de-
scribed above, individual increased IgG values occured
more often in group II than in group I; consequently
mean IgG values in group II were slightly higher than
in group I,
On the one hand, all the observations we made else-
where (3) for Kb/Xb in sera from patients affected with
amyotrophic lateral sclerosis, subacute sclerosing
panencephalitis and viral encephalitis were confirmed:
i. e., serum Kb/Xb in the range of controls were only
found in subacute sclerosing panencephalitis.
The serum Kb/Xb were decreased in viral encephalitis
and amyotrophic lateral sclerosis.
On the other hand, we were unable to reinforce our
earlier statement of a general kappa-increase in serum
from multiple sclerosis patients: when investigating an
additional 26 cases, we observed decreased as well as
increased Kb/Xb.
For the first time in the course of our investigations
we noticed 4 multiple sclerosis sera with definite
oligoclonal imm noglobulins and 4 others with a
tendency towards fractionation.
However the main subject of this paper is the presence
and the quantitative distribution of free light chains
in serum. Presence of free light chains in serum of
healthy donors has been reported by several authors
(5, 6, 7). However the quantitative values of free light
chains that we observed in control serum are not in
agreement with earlier findings: ours are much higher.
The fact that we used antisera directed exclusively
against free light chains, and finally that we used
Bence-Jones reference proteins could perhaps explain
J. Clin. Chem. Clin, Biochem. / Vol. 17,1979 / No. 1
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this fact. Discrepancies in results according to different
techniques used have been frequently noticed.
An analogous observation holds true for the ratio of
free kappa-lambda light chains; the ratios we observed
are much higher than those of earlier investigators
(7,8).
Nevertheless, the κί/Xf we obtained for controls are in
good agreement with the icb/Xb. If it is true, as has
been advanced by Shapiro et al. (9) that free light
chains are synthesized de novo rather than being a
breakdown product of intact immunoglobulins, one
must accept that in control sera more kappa light
chains are synthesized than lambda light chains, in
order to cope with the higher demand for kappa chains
since serum immunoglobulins are κ-predominant. The
good correlation between /cf/Xf and «b/Xb seems to
confirm this hypothesis.
In the neurological diseases that we investigated, the
underlying mechanism responsible for the distribution
of free light chains seems far from clear.
In amyotrophic lateral sclerosis five sera had increased
free κ-chains, four had increased free λ-chains and one
had particularly decreased λ-chains. The distribution
of Kf/Xf was in sharp contrast to the /cb/Xb.
In multiple sclerosis group I only the free X-chain
distribution was in good agreement with the controls;
as in amyotrophic lateral sclerosis, /cb/Xb were entirely
different from /<f/Xf; Kb/Xb showed a kappa increase
and /cf/Xf a kappa decrease when compared to control
values.
In group II the situation was the inverse, except for
the free lambda light chain range, which was once more
comparable to the control one.
Subacute sclerosing panencephalitis sera are character-
ized by a considerable increase of both free kappa and
lambda chains in a great many individual cases, although
mean kappa light chain values are not significantly
different from controls for the considered α-limits.
Subacute sclerosing panencephalitis is the only neuro-
logical disease where the mean /cb/Xb and the mean
Kf/Xf are in good correlation with each other.
Finally, when considering viral encephalitis sera it is
obvious that the free λ-chains are greatly increased.
This disease is also characterized by *f/Xf which are
very low in most cases. At a cellular level the production
of excess light chains could be due to either the
synthesis of only light chains by some cells while others
make equimolar amounts of both polypeptide chains,
or to the synthesis of more light than heavy chains by
all cells; the latter possibility seems more likely, since
Bernier & Cebra (10) presented immunofluorescent
evidence that in humans ah1 γ-globulin producing cells
contain both types of polypeptide chains. Light chains
are released autonomously from polyribosomes into
pool of free light chains. Askonas et al. (11) demonstrated
that during immunoglobulin synthesis light chain forma-
tion modulates heavy chain formation. One may perhaps
conclude that in normal conditions the small pool of
light chains serves as an intermediate of IgG molecules.
Shapiro et al. (9) reported that cell suspensions of
hyperimmunized rabbit lymph nodes synthesized and
secreted in the culture medium an excess of free light
chains. This explanation may thus account for the
appearance of free light chains in diseases in which an
immune mechanism is playing a role. However it is
difficult to know whether the light chains are produced
by cells making specific antibodies to the disease. Large
amounts of free light chains were found in sera and
urine of patients affected with systemic lupus ery thema-
tosus and in the synovi l fluids and urine of patients
with rheumatoid arthritis (12, 13). In the patients with
rheumatoid arthritis, the light chains were most
probably synthesized at sites of inflammation. In
systemic lupus erythematosus increased type lambda
protein was observed and one could advance the hypoth-
esis that this type of light chain could be characteristic
of the antibodies elaborated iri this disorder.
We have already observed that diseases such as subacute
sclerosing panencephalitis and viral encephalitis, where
hyperimmunisation has been established against measles
and herpes virus respectively, were characterized by a
considerable increase of free lambda light chains. More-
over, in a previous paper (1) we stated that particular
immunoglobulins, predominantly X-immunoglobulins,
are possibly synthesized in the cerebrospinal fluid of
subacute sclerosing panencephalitis; this fits well with
the present results from the serum of subacute sclerosing
panencephalitis patients.
In multiple sclerosis, a demyelinating disease, the great
number of clues to the pathogenesis of the disease is
frequently conflicting. One of them is that multiple
sclerosis could be a slow virus disease, or rather a virus
induced immune disease. However the presumed viral
immunisation is probably not to be compared to the
phenomenon of hyperimmunisation, as is noticed in
subacute sclerosing panencephalitis and viral encephali-
tis. It seems likely that as far as the free light chain
pool in multiple sclerosis sera is concerned, we are very
near the free light chain distribution of controls.
This could mean that in multiple sclerosis specific viral
antibodies or antibodies against tissue antigens are
almost exclusively restricted to the central nervous
system.
Conclusion
1. All the observations we reported earlier (1, 3) for
IgG content and fcb/Xb in serum from controls and
from patients with various neurological diseases were
confirmed, except for multiple sclerosis; indeed, when
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required.
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developments.
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investigating a larger group of multiple sclerosis sera
we no longer observed a general kappa increase.
2. The agar gel electrophoresis pattern of immuno-
globulins from sera of patients affected with amyo-
trophic lateral sclerosis, subacute sclerosing panen-
cephalitis and viral encephalitis was once more
confirmed, but for multiple sclerosis patients we now
observed a few sera with definite oligoclonal immuno-
gjobulins and several with a tendency towards fractiona-
tion.
In a previous paper (3) we suggested that in multiple
sclerosis oligoclonal immundglobulins could be present
in the serum, but that the few clones, possibly present,
were not yet sufficiently predominant in the hetero-
geneous background IgG.
According to the present findings in multiple sclerosis
sera, this seems to be true for a few cases at least.
3. We studied the quantitative distribution of free light
chains in 20 control sera, and assumed, on the one
hand, that in normal conditions the small pool of free
light chains perhaps serves as an intermediate of IgG
molecules; on the other hand, we stated that in order
to cope with the higher demands for kappa chain, more
kappa chains are synthesized than lambda chains.
4. In neurological diseases, which are accompanied
with hyperimmunisation, such as subacute sclerosing
panencephalitis and viral encephalitis, we advanced the
hypothesis that a particular type of free light chain,
which becomes especially predominant in the pool
of free light chains, could be characteristic of the specific
antibodies elaborated in the disorder, in serum as well
as in cerebrospinal fluid.
Elsewhere (3) we considered the presence of free light
chains in the cerebrospinal fluid as an index of either
hyperimmunisation, or strong immunological processes
in the central nervous system. On the basis of the
results we now report for subacute sclerosing panen-
cephalitis and viral encephalitis we may perhaps
conclude that prolonged residence of the virus in the
organism also affects the distribution of free light chain
in the serum.
This is not so surprising since in those diseases serum,
as well as cerebrospinal fluid, are characterized by
elevated titers in viral antibodies.
5. In multiple sclerosis the situation is controversial: on
the one hand serum free light chains are not increased
to such an extent as in subacute sclerosing panen-
cephalitis and viral encephalitis, and on the other hand
serum from multiple sclerosis patients is not characterized
by especially high titers of antibodies against a variety
of known viral antigens (15).
Although specific antibodies, possibly of the kappa chain
type, are most probably synthesized in the central
nervous system of multiple sclerosis patients (1, 2, 3,
16), it seems less likely that humoral antibodies of
central nervous system specificity directly related to
the disease are elaborated.
In multiple sclerosis, the viral etiology, although
strongly suspected, has never been clearly demonstrated
and demyelination is the paramount factor; this affects
solely white matter, whereas in subacute sclerosihg
panencephalitis and viral encephalitis both white and
gray matter are involved by inflammation, the responsible
antigen being most commonly a virus.
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